Perspective Therapeutics Inc. (CATX) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
2401 ELLIOTT AVENUE SEATTLE, WA 98121 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2024 MRQ | 12/31/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 9,238 | 55,890 | 63,828 | 2,392 | 5,326 | 3,425 | |||
| Cash and cash equivalents | 9,238 | 55,890 | 63,828 | 2,392 | 5,326 | 2,600 | |||
| Short-term investments | 825 | ||||||||
| Other undisclosed cash, cash equivalents, and short-term investments | |||||||||
| Receivables | 1,175 | 1,608 | 2,013 | 2,044 | 1,154 | 1,192 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,396 | 980 | 645 | 530 | 494 | ||||
| Inventory | 1,396 | 980 | 645 | 530 | 494 | ||||
| Prepaid expense | 1,078 | 391 | 443 | 382 | 201 | 274 | |||
| Disposal group, including discontinued operation | 5,301 | ||||||||
| Other current assets | 45 | 27 | 27 | 27 | 27 | 29 | |||
| Other undisclosed current assets | 17 | 11 | 17 | 77 | 32 | ||||
| Total current assets: | 16,837 | 59,329 | 67,302 | 5,507 | 7,315 | 5,446 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 2,333 | 76 | 137 | 155 | 319 | ||||
| Operating lease, right-of-use asset | 747 | 512 | 768 | 1,001 | ✕ | ✕ | |||
| Property, plant and equipment | 5,576 | 1,976 | 1,958 | 1,735 | 1,609 | 1,311 | |||
| Long-term investments and receivables | 133 | ||||||||
| Long-term investments | 133 | ||||||||
| Intangible assets, net (including goodwill) | 24,416 | ||||||||
| Goodwill | 24,062 | ||||||||
| Intangible assets, net (excluding goodwill) | 354 | ||||||||
| Restricted cash and investments | 182 | 182 | 182 | 181 | 181 | 181 | |||
| Other noncurrent assets | 487 | 107 | 130 | 138 | 162 | 198 | |||
| Other undisclosed noncurrent assets | 49,513 | ||||||||
| Total noncurrent assets: | 81,054 | 5,110 | 3,114 | 3,192 | 2,107 | 2,009 | |||
| TOTAL ASSETS: | 97,891 | 64,439 | 70,416 | 8,699 | 9,422 | 7,455 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 6,107 | 966 | 730 | 654 | 683 | 1,391 | |||
| Employee-related liabilities | ✕ | ✕ | 259 | 204 | 142 | 155 | |||
| Accrued liabilities | 460 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 5,647 | 966 | 471 | 450 | 541 | 1,236 | |||
| Deferred revenue | ✕ | ✕ | |||||||
| Debt | 49 | ||||||||
| Disposal group, including discontinued operation | 5,072 | ||||||||
| Other liabilities | 480 | 120 | 100 | 94 | 74 | 37 | |||
| Other undisclosed current liabilities | 3,956 | 1,180 | 971 | 827 | 364 | 407 | |||
| Total current liabilities: | 15,664 | 2,266 | 1,801 | 1,575 | 1,121 | 1,835 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1,676 | 256 | 524 | 769 | |||||
| Long-term debt, excluding current maturities | 1,676 | ||||||||
| Liabilities, other than long-term debt | 5,372 | 640 | 608 | 577 | 621 | 590 | |||
| Deferred revenue | ✕ | ✕ | |||||||
| Asset retirement obligations | 640 | 608 | 577 | 621 | 590 | ||||
| Deferred income tax liabilities | 4,592 | ✕ | ✕ | ||||||
| Other liabilities | |||||||||
| Operating lease, liability | 780 | 256 | 524 | 769 | ✕ | ✕ | |||
| Other undisclosed noncurrent liabilities | 77 | 55 | |||||||
| Total noncurrent liabilities: | 7,048 | 896 | 1,209 | 1,401 | 621 | 590 | |||
| Total liabilities: | 22,712 | 3,162 | 3,010 | 2,976 | 1,742 | 2,425 | |||
| Equity | |||||||||
| Equity, attributable to parent | 75,179 | 61,277 | 67,406 | 5,723 | 7,680 | 5,030 | |||
| Common stock | 282 | 142 | 142 | 69 | 67 | 56 | |||
| Additional paid in capital | 227,337 | 159,732 | 158,589 | 93,592 | 92,105 | 84,322 | |||
| Accumulated deficit | (152,440) | (98,597) | (91,325) | (87,938) | (84,492) | (79,348) | |||
| Total equity: | 75,179 | 61,277 | 67,406 | 5,723 | 7,680 | 5,030 | |||
| TOTAL LIABILITIES AND EQUITY: | 97,891 | 64,439 | 70,416 | 8,699 | 9,422 | 7,455 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,434 | 10,795 | 10,053 | 9,680 | 7,314 | 5,923 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (298) | (6,179) | (4,932) | (4,556) | (4,267) | (4,081) | ||
| Other undisclosed gross profit | 298 | |||||||
| Gross profit: | 1,434 | 4,616 | 5,121 | 5,124 | 3,047 | 1,842 | ||
| Operating expenses | (42,375) | (12,007) | (8,567) | (8,600) | (8,301) | (8,571) | ||
| Other undisclosed operating income | ||||||||
| Operating loss: | (40,941) | (7,391) | (3,446) | (3,476) | (5,254) | (6,729) | ||
| Nonoperating income | 835 | 119 | 59 | 30 | 110 | 29 | ||
| Investment income, nonoperating | 934 | 119 | 59 | 30 | 108 | 29 | ||
| Interest and debt expense | (84) | |||||||
| Loss from continuing operations before equity method investments, income taxes: | (40,190) | (7,272) | (3,387) | (3,446) | (5,144) | (6,700) | ||
| Loss from equity method investments | ||||||||
| Other undisclosed income from continuing operations before income taxes | 84 | |||||||
| Loss from continuing operations before income taxes: | (40,106) | (7,272) | (3,387) | (3,446) | (5,144) | (6,700) | ||
| Income tax expense (benefit) | 2,651 | |||||||
| Loss from continuing operations: | (37,455) | (7,272) | (3,387) | (3,446) | (5,144) | (6,700) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (7,272) | (3,387) | (3,446) | (5,144) | (6,700) | |
| Loss from discontinued operations | (9,053) | |||||||
| Other undisclosed net loss | ||||||||
| Net loss: | (46,508) | (7,272) | (3,387) | (3,446) | (5,144) | (6,700) | ||
| Other undisclosed net loss attributable to parent | ||||||||
| Net loss attributable to parent: | (46,508) | (7,272) | (3,387) | (3,446) | (5,144) | (6,700) | ||
| Preferred stock dividends and other adjustments | (3) | (11) | (11) | (11) | ||||
| Net loss available to common stockholders, diluted: | (46,508) | (7,272) | (3,390) | (3,457) | (5,155) | (6,711) | ||
Comprehensive Income ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (46,508) | (7,272) | (3,387) | (3,446) | (5,144) | (6,700) | ||
| Comprehensive loss, net of tax, attributable to parent: | (46,508) | (7,272) | (3,387) | (3,446) | (5,144) | (6,700) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.